ABE-Mediated Cardiac Gene Silencing via Single AAVs Requires DNA Accessibility.

Circ Res

School of Basic Medical Sciences, Institute of Cardiovascular Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Health Science Center, Beijing, China. (Z.L., L.Y., Y.Y., J.L., Z.C., C.G., Y.G.).

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.124.325611DOI Listing

Publication Analysis

Top Keywords

abe-mediated cardiac
4
cardiac gene
4
gene silencing
4
silencing single
4
single aavs
4
aavs requires
4
requires dna
4
dna accessibility
4
abe-mediated
1
gene
1

Similar Publications

ABE-Mediated Cardiac Gene Silencing via Single AAVs Requires DNA Accessibility.

Circ Res

January 2025

School of Basic Medical Sciences, Institute of Cardiovascular Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Health Science Center, Beijing, China. (Z.L., L.Y., Y.Y., J.L., Z.C., C.G., Y.G.).

View Article and Find Full Text PDF

Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping.

Mol Ther Methods Clin Dev

March 2023

Department of Surgery, Davis Heart and Lung Research Institute, Biomedical Sciences Graduate Program, Biophysics Graduate Program, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.

Duchenne muscular dystrophy (DMD) is caused by mutations in the gene. Previously, we showed that adenine base editing (ABE) can efficiently correct a nonsense point mutation in a DMD mouse model. Here, we explored the feasibility of base-editing-mediated exon skipping as a therapeutic strategy for DMD using cardiomyocytes derived from human induced pluripotent stem cells (hiPSCs).

View Article and Find Full Text PDF

BEON: A Functional Fluorescence Reporter for Quantification and Enrichment of Adenine Base-Editing Activity.

Mol Ther

July 2020

Department of Surgery, Davis Heart and Lung Research Institute, Biomedical Sciences Graduate Program, Biophysics Graduate Program, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. Electronic address:

Adenine base editor (ABE) is a new generation of genome-editing technology through fusion of Cas9 nickase with an evolved E. coli TadA (TadA∗) and holds great promise as novel genome-editing therapeutics for treating genetic disorders. ABEs can directly convert A-T to G-C in specific genomic DNA targets without introducing double-strand breaks (DSBs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!